In contrast, IL-12, which we showed was increased by MK2 inhibition, is characterized as a major contributor of enhanced cytotoxic function in anti-tumor immunity, while IL-10 promotes tumor progression [32,33,34,35]. The gene discussed is IL10; the disease is neoplasm.